Skip to main content
. 2022 Feb 22;12(2):e052790. doi: 10.1136/bmjopen-2021-052790

Table 6.

Pharmacological intervention after referral

Medication initiated Operational definition Scale of measurement
ESA therapy Initiation of ESA in participants whose Hb is <100 g/L Y or N. If yes, date of initiation or titration if available
ACE-I or ARB Initiation of ACE-I or ARB Y or N. If yes, date of initiation
Other antihypertensive medication Initiation of other antihypertensive medication Y or N. If yes, date of initiation
Calcium supplements Calcium supplements Y or N. If yes, date of initiation
Vitamin D supplements Vitamin D supplements Y or N. If yes, date of initiation
Lipid lowering drugs Lipid-lowering drugs Y or N. If yes, date of initiation
Loop diuretics Loop diuretics Y or N. If yes, date of initiation

ACE-I, ACE inhibitors; ARB, angiotensin receptor blockers; ESA, erythropoiesis stimulating agent; Hb, haemoglobin.